- Home
- BBIO vs RVTY Comparison
BBIO vs RVTY Comparison
Compare BBIO & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- RVTY
- Stock Information
- Founded
- BBIO 2015
- RVTY 1937
- Country
- BBIO United States
- RVTY United States
- Employees
- BBIO N/A
- RVTY N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- BBIO Health Care
- RVTY Industrials
- Exchange
- BBIO Nasdaq
- RVTY Nasdaq
- Market Cap
- BBIO 9.4B
- RVTY 9.8B
- IPO Year
- BBIO 2019
- RVTY N/A
- Fundamental
- Price
- BBIO $53.33
- RVTY $87.67
- Analyst Decision
- BBIO Strong Buy
- RVTY Buy
- Analyst Count
- BBIO 16
- RVTY 13
- Target Price
- BBIO $64.44
- RVTY $120.08
- AVG Volume (30 Days)
- BBIO 2.1M
- RVTY 1.2M
- Earning Date
- BBIO 11-11-2025
- RVTY 11-03-2025
- Dividend Yield
- BBIO N/A
- RVTY 0.32%
- EPS Growth
- BBIO N/A
- RVTY 72.56
- EPS
- BBIO N/A
- RVTY 2.37
- Revenue
- BBIO $235,812,000.00
- RVTY $2,798,467,000.00
- Revenue This Year
- BBIO $115.97
- RVTY $5.55
- Revenue Next Year
- BBIO $65.50
- RVTY $4.26
- P/E Ratio
- BBIO N/A
- RVTY $37.09
- Revenue Growth
- BBIO 7.62
- RVTY 3.33
- 52 Week Low
- BBIO $21.72
- RVTY $81.36
- 52 Week High
- BBIO $54.60
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- BBIO 60.01
- RVTY 50.33
- Support Level
- BBIO $49.94
- RVTY $81.69
- Resistance Level
- BBIO $54.29
- RVTY $88.49
- Average True Range (ATR)
- BBIO 2.06
- RVTY 2.78
- MACD
- BBIO -0.18
- RVTY 0.23
- Stochastic Oscillator
- BBIO 73.81
- RVTY 70.19
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.